OLMA logo

OLMA
Olema Pharmaceuticals Inc

1,802
Mkt Cap
$1.78B
Volume
857,442.00
52W High
$36.26
52W Low
$2.86
PE Ratio
-12.47
OLMA Fundamentals
Price
$22.59
Prev Close
$23.75
Open
$23.66
50D MA
$27.11
Beta
1.00
Avg. Volume
1.2M
EPS (Annual)
-$2.20
P/B
5.04
Rev/Employee
$0.00
$90.18
Loading...
Loading...
News
all
press releases
Olema Pharmaceuticals CEO Teases Fall OPERA-01 Readout, Q2 KAT6 Data and CFO/COO Exit
Olema Pharmaceuticals (NASDAQ:OLMA) is focused on developing endocrine therapies aimed at improving outcomes for patients with estrogen receptor (ER)-positive, HER2-negative breast cancer, CEO Sean...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
This Olema Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday
read more...
Benzinga·5d ago
News Placeholder
Olema Pharmaceuticals (NASDAQ:OLMA) Now Covered by Analysts at Stifel Nicolaus
Stifel Nicolaus assumed coverage on Olema Pharmaceuticals in a research report on Wednesday. They set a "buy" rating and a $48.00 price target for the company...
MarketBeat·5d ago
News Placeholder
Candriam S.C.A. Increases Stock Position in Olema Pharmaceuticals, Inc. $OLMA
Candriam S.C.A. raised its stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Free Report) by 46.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange...
MarketBeat·5d ago
News Placeholder
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Consensus Rating of "Moderate Buy" by Analysts
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) has been given an average rating of "Moderate Buy" by the ten brokerages that are currently covering the company, MarketBeat reports. One...
MarketBeat·10d ago
News Placeholder
Short Interest in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Decreases By 12.5%
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) was the recipient of a large decrease in short interest in January. As of January 15th, there was short interest totaling 9,100,561 shares...
MarketBeat·13d ago
News Placeholder
Olema Pharmaceuticals (NASDAQ:OLMA) Trading 7.7% Higher - Here's What Happened
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 7.7% - Here's Why...
MarketBeat·18d ago
News Placeholder
Olema Pharmaceuticals (NASDAQ:OLMA) Director Sells 10,000 Shares
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) Director Cyrus Harmon sold 10,000 shares of Olema Pharmaceuticals stock in a transaction on Tuesday, January 20th. The stock was sold at an...
MarketBeat·25d ago
News Placeholder
Olema Pharmaceuticals (NASDAQ:OLMA) Director Cyrus Harmon Sells 10,000 Shares
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) Director Cyrus Harmon sold 10,000 shares of the firm's stock in a transaction that occurred on Tuesday, January 20th. The shares were sold...
MarketBeat·26d ago
News Placeholder
Olema Pharmaceuticals (NASDAQ:OLMA) Director Sells $101,599.68 in Stock
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) Director Cyrus Harmon sold 3,489 shares of the business's stock in a transaction on Wednesday, January 14th. The stock was sold at an...
MarketBeat·26d ago
<
1
2
...
>

Latest OLMA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.